This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: California Institute of Technology. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations of Ronghui Zhu in Protein Signal Thresholding
Introduction
Ronghui Zhu is an accomplished inventor based in Pasadena, California. He has made significant contributions to the field of synthetic biology, particularly in the area of protein signaling. With a total of two patents to his name, Zhu's work focuses on developing innovative methods for controlling protein signals in biological systems.
Latest Patents
Zhu's latest patents include a synthetic system for tunable thresholding of protein signals. This invention discloses methods, compositions, and kits that are suitable for thresholding protein signals. In some embodiments, the synthetic protein circuits respond to inputs only when they exceed or fall below a specific threshold concentration. Additionally, the threshold value itself can be adjusted, providing flexibility in its application. The methods outlined in the patent also include approaches for treating diseases or disorders characterized by aberrant signaling.
Career Highlights
Ronghui Zhu is affiliated with the California Institute of Technology, where he continues to advance research in synthetic biology. His work has garnered attention for its potential applications in medical treatments and biotechnology.
Collaborations
Zhu collaborates with notable colleagues, including Lucy S Chong and Xiaofei Ge, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Ronghui Zhu's contributions to the field of synthetic biology, particularly through his patents on tunable thresholding of protein signals, highlight his role as a leading inventor. His work not only advances scientific understanding but also opens new avenues for medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
